|
CASP6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.216000E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.943200E-03 |
| Normal-vs-Stage2 |
6.566400E-01 |
| Normal-vs-Stage3 |
5.053900E-02 |
| Normal-vs-Stage4 |
5.891600E-01 |
| Stage1-vs-Stage2 |
2.173600E-01 |
| Stage1-vs-Stage3 |
9.187000E-01 |
| Stage1-vs-Stage4 |
1.757570E-01 |
| Stage2-vs-Stage3 |
3.135400E-01 |
| Stage2-vs-Stage4 |
9.718400E-01 |
| Stage3-vs-Stage4 |
2.822000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.981980E-02 |
| Normal-vs-AfricanAmerican |
3.702000E-02 |
| Normal-vs-Asian |
2.827800E-01 |
| Caucasian-vs-AfricanAmerican |
6.427400E-01 |
| Caucasian-vs-Asian |
1.442620E-01 |
| AfricanAmerican-vs-Asian |
6.633800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.340490E-02 |
| Normal-vs-Female |
1.437190E-01 |
| Male-vs-Female |
3.005800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.112100E-02 |
| Normal-vs-Age(41-60Yrs) |
8.697600E-02 |
| Normal-vs-Age(61-80Yrs) |
4.243900E-02 |
| Normal-vs-Age(81-100Yrs) |
8.438300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.171200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.008000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.430000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.314800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.037250E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.591000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.142200E-01 |
| Normal-vs-Grade 2 |
7.638200E-02 |
| Normal-vs-Grade 3 |
1.533660E-02 |
| Normal-vs-Grade 4 |
2.638200E-01 |
| Grade 1-vs-Grade 2 |
7.464600E-01 |
| Grade 1-vs-Grade 3 |
9.624400E-01 |
| Grade 1-vs-Grade 4 |
6.298600E-01 |
| Grade 2-vs-Grade 3 |
5.327200E-01 |
| Grade 2-vs-Grade 4 |
7.951000E-01 |
| Grade 3-vs-Grade 4 |
4.404400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.384500E-03 |
| Normal-vs-ccB subtype |
3.203000E-01 |
| ccA subtype-vs-ccB subtype |
5.392200E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.460100E-02 |
| Normal-vs-N1 |
5.895800E-01 |
| N0-vs-N1 |
2.677400E-01 |
|
|
